MLICM
HAE icon

Metropolitan Life Insurance Company (MetLife)’s Haemonetics HAE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,636
Closed -$225K – 907
2024
Q1 		$225K Sell
2,636
-252
-9% -$19.8K 0.01% 666
2023
Q4 		$247K Hold
2,888
– – 0.01% 649
2023
Q3 		$259K Buy
2,888
+153
+6% +$13.7K 0.01% 582
2023
Q2 		$233K Hold
2,735
– – 0.01% 618
2023
Q1 		$226K Sell
2,735
-467
-15% -$37.8K 0.01% 627
2022
Q4 		$252K Buy
3,202
+138
+5% +$11.1K 0.01% 625
2022
Q3 		$227K Hold
3,064
– – 0.01% 633
2022
Q2 		$200K Sell
3,064
-212
-6% -$12.5K 0.01% 695
2022
Q1 		$207K Sell
3,276
-18,045
-85% -$981K 0.01% 797
2021
Q4 		$1.13M Sell
21,321
-167
-0.8% -$10.2K 0.02% 881
2021
Q3 		$1.52M Sell
21,488
-967
-4% -$61K 0.02% 673
2021
Q2 		$1.5M Buy
22,455
+10,393
+86% +$735K 0.02% 714
2021
Q1 		$1.34M Buy
12,062
+351
+3% +$43.4K 0.02% 755
2020
Q4 		$1.39M Sell
11,711
-271
-2% -$29.2K 0.02% 664
2020
Q3 		$1.05M Sell
11,982
-520
-4% -$45.4K 0.02% 719
2020
Q2 		$1.12M Sell
12,502
-14,775
-54% -$1.49M 0.02% 671
2020
Q1 		$2.72M Sell
27,277
-1,403
-5% -$152K 0.06% 288
2019
Q4 		$3.3M Sell
28,680
-375
-1% -$45.4K 0.05% 319
2019
Q3 		$3.66M Sell
29,055
-870
-3% -$110K 0.06% 262
2019
Q2 		$3.6M Buy
29,925
+55
+0.2% +$5.41K 0.06% 274
2019
Q1 		$2.61M Sell
29,870
-421
-1% -$38.3K 0.05% 345
2018
Q4 		$3.03M Buy
30,291
+279
+0.9% +$29.3K 0.06% 263
2018
Q3 		$3.44M Sell
30,012
-1,054
-3% -$109K 0.06% 276
2018
Q2 		$2.79M Buy
31,066
+14,444
+87% +$1.22M 0.05% 350
2018
Q1 		$1.22M Sell
16,622
-504
-3% -$34.6K 0.02% 811
2017
Q4 		$995K Sell
17,126
-17,824
-51% -$939K 0.01% 889
2017
Q3 		$1.57M Hold
34,950
– – 0.01% 1026
2017
Q2 		$1.38M Hold
34,950
– – 0.01% 1086
2017
Q1 		$1.42M Hold
34,950
– – 0.01% 1077
2016
Q4 		$1.41M Sell
34,950
-3,254
-9% -$123K 0.01% 1120
2016
Q3 		$1.38M Sell
38,204
-382
-1% -$13.1K 0.01% 1108
2016
Q2 		$1.12M Hold
38,586
– – 0.01% 1197
2016
Q1 		$1.35M Buy
38,586
+2,419
+7% +$78.1K 0.01% 1041
2015
Q4 		$1.17M Buy
36,167
+411
+1% +$13.3K 0.01% 1111
2015
Q3 		$1.16M Sell
35,756
-818
-2% -$30.8K 0.01% 1120
2015
Q2 		$1.51M Sell
36,574
-4,710
-11% -$199K 0.01% 1069
2015
Q1 		$1.85M Hold
41,284
– – 0.01% 912
2014
Q4 		$1.54M Buy
41,284
+665
+2% +$24.4K 0.01% 1073
2014
Q3 		$1.42M Sell
40,619
-1,161
-3% -$41.4K 0.01% 1082
2014
Q2 		$1.47M Hold
41,780
– – 0.01% 1126
2014
Q1 		$1.36M Sell
41,780
-276
-0.7% -$10.5K 0.01% 1149
2013
Q4 		$1.77M Buy
42,056
+237
+0.6% +$9.75K 0.01% 1033
2013
Q3 		$1.67M Hold
41,819
– – 0.01% 1027
2013
Q2 		$1.73M Buy
+41,819
New +$1.69M 0.01% 963

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s HAE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 2,636 shares — an estimated $225K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HAE in Q2 2013 and held it in 44 quarters. The position peaked at $3.66M in Q3 2019. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,636 Haemonetics shares in Q2 2024, an estimated $225K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Haemonetics in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Haemonetics position peaked at $3.66M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.